M
Michael Krebs
Researcher at Medical University of Vienna
Publications - 178
Citations - 5952
Michael Krebs is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Insulin resistance & Insulin. The author has an hindex of 34, co-authored 157 publications receiving 5097 citations. Previous affiliations of Michael Krebs include KTU Faculty of Medicine & University of Vienna.
Papers
More filters
Journal ArticleDOI
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance.
Frédéric Tremblay,Sophie Brûlé,Sung Hee Um,Yu Li,Kohei Masuda,Michael Roden,Xiao Jian Sun,Michael Krebs,Roberto D. Polakiewicz,George Thomas,André Marette +10 more
TL;DR: It is shown that S6K1 directly phosphorylates IRS-1 Ser-1101 in vitro in the C-terminal domain of the protein and that mutation of this site largely blocks the ability of amino acids to suppress IRS- 1 tyrosine and Akt phosphorylation.
Journal ArticleDOI
Mechanism of Amino Acid-Induced Skeletal Muscle Insulin Resistance in Humans
Michael Krebs,Martin Krššák,Elisabeth Bernroider,Christian Anderwald,Attila Brehm,Martin Meyerspeer,Peter Nowotny,Erich Roth,Werner Waldhäusl,Michael Roden +9 more
TL;DR: Effects of short-term plasma amino acid elevation induces skeletal muscle insulin resistance in humans by inhibition of glucose transport/phosphorylation, resulting in marked reduction of glycogen synthesis.
Journal ArticleDOI
Overactivation of S6 Kinase 1 as a Cause of Human Insulin Resistance During Increased Amino Acid Availability
Frédéric Tremblay,Michael Krebs,Luce Dombrowski,Attila Brehm,Elisabeth Bernroider,Erich Roth,Peter Nowotny,Werner Waldhäusl,André Marette,Michael Roden +9 more
TL;DR: It is suggested that overactivation of the mammalian target of rapamycin/S6 kinase 1 pathway and inhibitory serine phosphorylation of insulin receptor substrate-1 underlie the impairment of insulin action in amino acid-infused humans.
Journal ArticleDOI
Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: Recommendations and future directions
Adnan Sharif,Manfred Hecking,A. P. J. de Vries,Esteban Porrini,Mads Hornum,Susanne Rasoul-Rockenschaub,Gabriela A. Berlakovich,Michael Krebs,Alexandra Kautzky-Willer,Gerit-Holger Schernthaner,Piero Marchetti,Giovanni Pacini,Akinlolu O. Ojo,Shiro Takahara,J.L. Larsen,Katharina Birgit Budde,Kathrin Eller,J. Pascual,Alan G. Jardine,Stephan J. L. Bakker,Tone Gretland Valderhaug,Trond Jenssen,S. Cohney,Marcus D. Säemann +23 more
TL;DR: A consensus meeting was held in Vienna on September 8-9, 2013, to discuss diagnostic and therapeutic challenges surrounding development of diabetes mellitus after transplantation as mentioned in this paper, where 24 transplant nephrologists, surgeons, diabetologists and clinical scientists met with the aim to review previous guidelines in light of emerging clinical data and research.
Journal ArticleDOI
Reflux, Sleeve Dilation, and Barrett's Esophagus after Laparoscopic Sleeve Gastrectomy: Long-Term Follow-Up.
Daniel M Felsenreich,Ronald Kefurt,Martin Schermann,Philipp Beckerhinn,Ivan Kristo,Michael Krebs,Gerhard Prager,Felix B. Langer +7 more
TL;DR: A high incidence of Barrett’s esophagus and hiatal hernias is shown at more than 10 years after Laparoscopic sleeve gastrectomy, suggesting maintaining pre-existing large hiatAL hernia, GERD, and Barrett's esophageal reflux as relative contraindications to SG.